Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
Transgenic rat models of Alzheimer's disease were used to examine differences in memory and brain histology. Double transgenic female rats (APP+PS1) over-expressing human amyloid precursor protein (APP) and presenilin 1 (PS1) and single transgenic rats (APP21) over-expressing human APP were com...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5895023?pdf=render |
| _version_ | 1818367652170563584 |
|---|---|
| author | Diana Klakotskaia Cansu Agca Rachel A Richardson Edward G Stopa Todd R Schachtman Yuksel Agca |
| author_facet | Diana Klakotskaia Cansu Agca Rachel A Richardson Edward G Stopa Todd R Schachtman Yuksel Agca |
| author_sort | Diana Klakotskaia |
| collection | DOAJ |
| description | Transgenic rat models of Alzheimer's disease were used to examine differences in memory and brain histology. Double transgenic female rats (APP+PS1) over-expressing human amyloid precursor protein (APP) and presenilin 1 (PS1) and single transgenic rats (APP21) over-expressing human APP were compared with wild type Fischer rats (WT). The Barnes maze assessed learning and memory and showed that both APP21 and APP+PS1 rats made significantly more errors than the WT rats during the acquisition phase, signifying slower learning. Additionally, the APP+PS1 rats made significantly more errors following a retention interval, indicating impaired memory compared to both the APP21 and WT rats. Immunohistochemistry using an antibody against amyloid-β (Aβ) showed extensive and mostly diffuse Aβ plaques in the hippocampus and dense plaques that contained tau in the cortex of the brains of the APP+PS1 rats. Furthermore, the APP+PS1 rats also showed vascular changes, including cerebral amyloid angiopathy with extensive Aβ deposits in cortical and leptomeningeal blood vessel walls and venous collagenosis. In addition to the Aβ accumulation observed in arterial, venous, and capillary walls, APP+PS1 rats also displayed enlarged blood vessels and perivascular space. Overall, the brain histopathology and behavioral assessment showed that the APP+PS1 rats demonstrated behavioral characteristics and vascular changes similar to those commonly observed in patients with Alzheimer's disease. |
| first_indexed | 2024-12-13T22:55:27Z |
| format | Article |
| id | doaj.art-1ac8b47461b74df388734eaf96521b84 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-13T22:55:27Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-1ac8b47461b74df388734eaf96521b842022-12-21T23:28:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01134e019546910.1371/journal.pone.0195469Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.Diana KlakotskaiaCansu AgcaRachel A RichardsonEdward G StopaTodd R SchachtmanYuksel AgcaTransgenic rat models of Alzheimer's disease were used to examine differences in memory and brain histology. Double transgenic female rats (APP+PS1) over-expressing human amyloid precursor protein (APP) and presenilin 1 (PS1) and single transgenic rats (APP21) over-expressing human APP were compared with wild type Fischer rats (WT). The Barnes maze assessed learning and memory and showed that both APP21 and APP+PS1 rats made significantly more errors than the WT rats during the acquisition phase, signifying slower learning. Additionally, the APP+PS1 rats made significantly more errors following a retention interval, indicating impaired memory compared to both the APP21 and WT rats. Immunohistochemistry using an antibody against amyloid-β (Aβ) showed extensive and mostly diffuse Aβ plaques in the hippocampus and dense plaques that contained tau in the cortex of the brains of the APP+PS1 rats. Furthermore, the APP+PS1 rats also showed vascular changes, including cerebral amyloid angiopathy with extensive Aβ deposits in cortical and leptomeningeal blood vessel walls and venous collagenosis. In addition to the Aβ accumulation observed in arterial, venous, and capillary walls, APP+PS1 rats also displayed enlarged blood vessels and perivascular space. Overall, the brain histopathology and behavioral assessment showed that the APP+PS1 rats demonstrated behavioral characteristics and vascular changes similar to those commonly observed in patients with Alzheimer's disease.http://europepmc.org/articles/PMC5895023?pdf=render |
| spellingShingle | Diana Klakotskaia Cansu Agca Rachel A Richardson Edward G Stopa Todd R Schachtman Yuksel Agca Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. PLoS ONE |
| title | Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. |
| title_full | Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. |
| title_fullStr | Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. |
| title_full_unstemmed | Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. |
| title_short | Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. |
| title_sort | memory deficiency cerebral amyloid angiopathy and amyloid β plaques in app ps1 double transgenic rat model of alzheimer s disease |
| url | http://europepmc.org/articles/PMC5895023?pdf=render |
| work_keys_str_mv | AT dianaklakotskaia memorydeficiencycerebralamyloidangiopathyandamyloidbplaquesinappps1doubletransgenicratmodelofalzheimersdisease AT cansuagca memorydeficiencycerebralamyloidangiopathyandamyloidbplaquesinappps1doubletransgenicratmodelofalzheimersdisease AT rachelarichardson memorydeficiencycerebralamyloidangiopathyandamyloidbplaquesinappps1doubletransgenicratmodelofalzheimersdisease AT edwardgstopa memorydeficiencycerebralamyloidangiopathyandamyloidbplaquesinappps1doubletransgenicratmodelofalzheimersdisease AT toddrschachtman memorydeficiencycerebralamyloidangiopathyandamyloidbplaquesinappps1doubletransgenicratmodelofalzheimersdisease AT yukselagca memorydeficiencycerebralamyloidangiopathyandamyloidbplaquesinappps1doubletransgenicratmodelofalzheimersdisease |